Top compounds associated with response to SLC2A9


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0073 0.8
mRNA PLX4720 CTRPv2 pan-cancer AAC -0.0076 0.8
mRNA salermide CTRPv2 pan-cancer AAC 0.0094 0.8
mRNA SR8278 CTRPv2 pan-cancer AAC -0.027 0.8
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.0069 0.8
mRNA AR-42 GDSC1000 pan-cancer AAC 0.0064 0.8
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.0075 0.8
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0077 0.8
mRNA Cisplatin GDSC1000 pan-cancer AAC -0.0069 0.8
mRNA brivanib CTRPv2 pan-cancer AAC -0.0071 0.9
Download CSV